Meccano Regression Index

Dear colleagues

The more you prescribe drugs, e.g. in cardiology, the lower will be your regression index calculated by santésuisse! Here you may learn, how the santésuisse regression index is constructed and how you may protect yourself from repayments of your money to santésuisse.

Base Case Scenario

Let us assume that you have 1,000 patients annually and that you charge an average of CHF 850 CHF per patient for diagnostic work ups (without other costs for medication ecc).

Let us also assume that these 1,000 patients have the same number of hospitalizations as all the other cardiologists with whom you are compared by santésuisse in the previous year (we shall get back on this). All the variables in santésuisse’s regression index are assumed to be comparable to your practice, with one exception:

You do not prescribe drugs!

Now you may think that you are at least a cheap doctor who is not at risk of an increased regression index and who is not at risk of having to pay back a part your income to santésuisse. This feeling was correct until 2016 with the old ANOVA index. With the new Regression Index, working since 2017, things are inversed. Formerly cheap doctors have now a very high regression index. Why?

We will gladly do a situation analysis for you. So, your spending is 850’000 CHF per year for the diagnostic work-up of your 1’000 patients. Unfortunately for you, the comparison group has a certain number of cardiologists, who are drug prescribers: Statins, Ezetimibe, PCSK9-inhibitors, Inclisiran, Nitrates, Amiodarone, Diuretics, antihypertensives, Jardiance, Betablockers, new oral Anticoagulants, low-dose Aspirin, Ivabradine and Sildenafil or Entresto. The mix of these prescriptions reduces the groups regression index.

Here is our Base-Case Modelling


How can you reduce this fine to zero? Here the story goes on!